Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No dilution with updated SS showing maxed out:
UPDATED LAHO SS:
AS - 4,000,000,000
OS - 3,998,451,160
Room remaining on current OS: 1,548,840 shares
https://www.otcmarkets.com/stock/LAHO/security
Comprehensive $LAHO DD - next penny runner:
***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)***
***Awaiting final closure mega reverse merger of LAHO/GSCG by October 23rd (within 150 days from binding LOI executed on May 23rd and filed as an 8K on May 28th)
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
REVERSE MERGER ANNOUNCEMENT
Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group (GSCG)
https://globenewswire.com/news-release/2019/05/28/1853115/0/en/Lans-Holdings-Enters-into-Binding-LOI-to-Acquire-Global-Stem-Cells-Group.html
SEC FORM 8K (Binding LOI to acquire GSCG)
https://www.otcmarkets.com/filing/html?id=13457482&guid=
GSCG has 41 stem cell centers in 25 countries globally, plus the Adimarket which sells products and recently outfits a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
Benito Novas of Aesthetica Marketing Group Set as Keynote for Chilean Aesthetics Congress (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers-2/
Adimarket, LLC Launches New Product for Physicians Seeking to Create Regenerative Medicine and Stem Cell Treatment Centers (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers/
GSCG: Stem Cells Group to Host Regenerative Medicine Symposium at the University of Miami (June 26, 2019)
http://www.stemcellsgroup.com/stem-cells-group-to-host-regenerative-medicine-symposium-at-the-university-of-miami/
GSCG: Global Stem Cells Group to Host Argentina Lectures on Newest Stem Cells Therapies (June 26, 2019)
http://www.stemcellsgroup.com/global-stem-cells-group-to-host-argentina-lectures-on-newest-stem-cells-therapies/
GSCG: ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center: The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France. GSCG’s Adimarket store will all provide equipment and supplies to the facility. (June 26, 2019)
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
To learn more about Churchill Aesthetic Center, visit https://www.churchill-aesthetic-center.be/. To learn more about ISSCA, visit https://issca.us/
LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers (June 12, 2019)
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GLOBAL STEM CELLS GROUP WEBSITE--GSCG
http://www.stemcellsgroup.com/
GSCG HAS AN ONLINE STORE FOR REGENERATIVE MEDICINE PRACTITIONERS
GSCG REVENUE ($29 million):
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
GSCG--Adimarket - Turn-Key Solution for Regenerative Medicine
https://www.adimarket.net/
Zoominfo says that Adimart, Inc (Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies) has $10 million in revenue with a breakdown of 2.4 million average quarterly in 2018.
https://www.zoominfo.com/c/adimarket-inc/359689609
Lans Holdings posted a message about the LOI on its Linked in
https://www.linkedin.com/company/lans-holdings-inc?trk=similar-companies_org_title
CEO Benito Novas has some impressive credentials and accolades
https://www.linkedin.com/in/benito-novas-671a4122?trk=org-employees_mini-profile_title
Here’s the YouTube channel for GSCG (videos of CEO speaking, conferences, explanations of the company and its processes, etc)
https://www.youtube.com/user/StemCellsGroup
I’m going to feel the fear and DO IT ANYWAY! I’m increasing my position next week. Cheers everyone!
Comprehensive $LAHO DD - next penny runner:
***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)
—————————————————-
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
REVERSE MERGER ANNOUNCEMENT
Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group (GSCG)
https://globenewswire.com/news-release/2019/05/28/1853115/0/en/Lans-Holdings-Enters-into-Binding-LOI-to-Acquire-Global-Stem-Cells-Group.html
SEC FORM 8K (Binding LOI to acquire GSCG)
https://www.otcmarkets.com/filing/html?id=13457482&guid=
GSCG has 41 stem cell centers in 25 countries globally, plus the Adimarket which sells products and recently outfits a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
Benito Novas of Aesthetica Marketing Group Set as Keynote for Chilean Aesthetics Congress (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers-2/
Adimarket, LLC Launches New Product for Physicians Seeking to Create Regenerative Medicine and Stem Cell Treatment Centers (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers/
GSCG: Stem Cells Group to Host Regenerative Medicine Symposium at the University of Miami (June 26, 2019)
http://www.stemcellsgroup.com/stem-cells-group-to-host-regenerative-medicine-symposium-at-the-university-of-miami/
GSCG: Global Stem Cells Group to Host Argentina Lectures on Newest Stem Cells Therapies (June 26, 2019)
http://www.stemcellsgroup.com/global-stem-cells-group-to-host-argentina-lectures-on-newest-stem-cells-therapies/
GSCG: ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center: The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France. GSCG’s Adimarket store will all provide equipment and supplies to the facility. (June 26, 2019)
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
To learn more about Churchill Aesthetic Center, visit https://www.churchill-aesthetic-center.be/. To learn more about ISSCA, visit https://issca.us/
LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers (June 12, 2019)
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GLOBAL STEM CELLS GROUP WEBSITE--GSCG
http://www.stemcellsgroup.com/
GSCG HAS AN ONLINE STORE FOR REGENERATIVE MEDICINE PRACTITIONERS
GSCG REVENUE ($29 million):
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
GSCG--Adimarket - Turn-Key Solution for Regenerative Medicine
https://www.adimarket.net/
Zoominfo says that Adimart, Inc (Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies) has $10 million in revenue with a breakdown of 2.4 million average quarterly in 2018.
https://www.zoominfo.com/c/adimarket-inc/359689609
Lans Holdings posted a message about the LOI on its Linked in
https://www.linkedin.com/company/lans-holdings-inc?trk=similar-companies_org_title
CEO Benito Novas has some impressive credentials and accolades
https://www.linkedin.com/in/benito-novas-671a4122?trk=org-employees_mini-profile_title
Here’s the YouTube channel for GSCG (videos of CEO speaking, conferences, explanations of the company and its processes, etc)
https://www.youtube.com/user/StemCellsGroup
That’s what I was thinking. This dude is a visionary. Many will be surprised here in 6-9 months from now
Benito speaking (in English) after receiving a 2018 award at a ceremony. Start listening from 0:35
By the way, I forgot to mention that LAHO IR finally responded to my email from early July on this past Monday, July 29, the day news came out. In their email back to me they stated:
Dear Investor, thank you for your interest in Lans Holdings and for taking the time to read our Press Releases and SEC filings. Thank you also for considering investing your precious resources in our company. Lans Holdings is stating through our latest PR that the due diligence period of 60 days is complete and is satisfied with the material needed to be disclosed. We are looking forward to the closing of the acquisition.
We are also excited about the engagement of our new auditors, as we move forward to complete all required audits and reviews to bring the company back to current status.
Please see our changes to our website as well at www.lans.holdings
Investor Relations
LAHO
-----Original Message-----
From:
Sent: Wednesday, July 10, 2019 11:20 AM
To: investors@lans.holdings
Subject: Question regarding Lans Holdings/GSCG reverse merger
Hello,
I am a current investor in Lans Holdings which a recent company SEC filing on May 28 indicated that your company & Global Stem Cells Group entered into a binding LOI that would reverse merge the two companies upon completion of a 60 day due diligence period (DD) and 150 closing period from May 23rd. As that DD period comes to a close on July 22, I was wondering if there was any status update and/or additional information that could be provided on the DD process or whether it has been completed satisfactorily. I also was curious how your company plans to channel its expertise in online transactions to potentially benefit GSCG’s online Adimarket store following the completion of this acquisition. Any updates or information that can be shared would be most helpful. Thank you.
Excellent post. GSCG is no sham company and they are an emerging leader in the stem cell arena with real progress and tons of videos documenting its work.
Here’s the YouTube channel for GSCG (videos of CEO speaking, conferences, explanations of the company and its processes, etc)
https://www.youtube.com/user/StemCellsGroup
GSCG CEO Benito Novas has some impressive credentials and accolades
https://www.linkedin.com/in/benito-novas-671a4122?trk=org-employees_mini-profile_title
Comprehensive $LAHO DD - next penny runner:
***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)
—————————————————-
REVERSE MERGER ANNOUNCEMENT
Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group (GSCG)
https://globenewswire.com/news-release/2019/05/28/1853115/0/en/Lans-Holdings-Enters-into-Binding-LOI-to-Acquire-Global-Stem-Cells-Group.html
SEC FORM 8K (Binding LOI to acquire GSCG)
https://www.otcmarkets.com/filing/html?id=13457482&guid=
GSCG has 36 stem cell centers in 27 countries globally, plus the Adimarket which sells products and recently outfits a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
Benito Novas of Aesthetica Marketing Group Set as Keynote for Chilean Aesthetics Congress (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers-2/
Adimarket, LLC Launches New Product for Physicians Seeking to Create Regenerative Medicine and Stem Cell Treatment Centers (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers/
GSCG: Stem Cells Group to Host Regenerative Medicine Symposium at the University of Miami (June 26, 2019)
http://www.stemcellsgroup.com/stem-cells-group-to-host-regenerative-medicine-symposium-at-the-university-of-miami/
GSCG: Global Stem Cells Group to Host Argentina Lectures on Newest Stem Cells Therapies (June 26, 2019)
http://www.stemcellsgroup.com/global-stem-cells-group-to-host-argentina-lectures-on-newest-stem-cells-therapies/
GSCG: ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center: The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France. GSCG’s Adimarket store will all provide equipment and supplies to the facility. (June 26, 2019)
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
To learn more about Churchill Aesthetic Center, visit https://www.churchill-aesthetic-center.be/. To learn more about ISSCA, visit https://issca.us/
LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers (June 12, 2019)
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GLOBAL STEM CELLS GROUP WEBSITE--GSCG
http://www.stemcellsgroup.com/
GSCG HAS AN ONLINE STORE FOR REGENERATIVE MEDICINE PRACTITIONERS
GSCG REVENUE ($29 million):
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
GSCG--Adimarket - Turn-Key Solution for Regenerative Medicine
https://www.adimarket.net/
Zoominfo says that Adimart, Inc (Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies) has $10 million in revenue with a breakdown of 2.4 million average quarterly in 2018.
https://www.zoominfo.com/c/adimarket-inc/359689609
Lans Holdings posted a message about the LOI on its Linked in
https://www.linkedin.com/company/lans-holdings-inc?trk=similar-companies_org_title
Pumpers are hyperbolic and declaring multiple dollars. Positive folks are aware of the bullish trend of the this stock’s technical analysis and charting and responding accordingly. Most here are just positive folks.
They cannot dilute more than 1.5 mil more shares right now because the updated SS number show the OS at 3.99 billion with a 4 billion AS. This is retail flipping or being plain impatient. The RM will be formally completed very soon and the name change is coming thereafter. These impatient folks may go on to other plays. But none of those plays will be as rewarding as this one. Guaranteed.
Once the first GSCG financials come out late this year or likely early next year and they show that the company is making millions then there will be a monumental move from wherever we are at at that time. And the pps will be well above a penny when those fins get released.
Perhaps you should read about LAHO’s Paysperity platform.
https://paysperity.com
Their Paysperity platform could work in very well with GSCG’s online Adimarket store which sells stem cell equipment, supplies, and starter packages for new stem cell centers.
https://www.adimarket.net
Zoominfo says that Adimart, Inc (Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies) has $10 million in revenue with a breakdown of 2.4 million average quarterly in 2018.
https://www.zoominfo.com/c/adimarket-inc/359689609
Adimarket, LLC Launches New Product for Physicians Seeking to Create Regenerative Medicine and Stem Cell Treatment Centers (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers/
GSCG: ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center: The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France. GSCG’s Adimarket store will all provide equipment and supplies to the facility. (June 26, 2019)
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Also, SOL* has had the dark/defunct designation, shell risk designation and caveat emptor designation since prior to the RM announcement that launched it from .0007 above a dollar. It still has those designations and is still on the greys despite current financials. So success can still be achieved with less than ideal conditions. We on the other hands only have the SEC non-compliance designation which is about to be lifted within 6 weeks. I like our chances here much better than any others out there right now.
SOL* wasn’t current and on the greys and it went from .0007 to to $1+ within 6 months after announcing its binding RM. There are many others. These are pinks not blue chips. They are going to have flaws and imperfections. The LAHO/GSCG RM is a once in a blue moon arrangement we have upon us. The people that miss this opportunity will disappointed. Just my two cents.
Again, there is a time and place for everything. Dilution is not always a bad thing. Every company does it when it is necessary. LAHO has had to do it to make this merger possible.
Mandatory reading:
https://seekingalpha.com/article/1787022-when-dilution-is-a-buy-signal
It is for now except for the 1.5mil left on the OS which could have been dumped today. It’s fair to say dilution is over until they go current and eventually increase the AS. Hopefully that eventual increase comes with caution and with the proper timing. But it’s nice to know that since they are maxed out on AS/OS they will be working quickly to get financials current and compliant in order to be able to address the SS going forward. I think mgmt for both companies knows the market will eventually correct course in a big way in terms of pps and valuation once the RM is finalized and they reveal more about GSCG’s revenue/earnings and future plans.
By the way, dilution is NOT always a negative. In fact, it can be a buy signal and positive for these reasons:
https://seekingalpha.com/article/1787022-when-dilution-is-a-buy-signal
UPDATED LAHO SS:
AS - 4,000,000,000
OS - 3,998,451,160
Room remaining on current OS: 1,548,840 shares
https://www.otcmarkets.com/stock/LAHO/security
LAHO has payment processing experience which can be very helpful to GSCG’s subsidiary, Adimarket.
Its not my job to teach how to interpret LAHO DD and DD for any ticker. But there’s a ton of resources online to help you understand. Cheers. $LAHO
Agreed. Also it will support the hypothesis that the current status and finalization of the acquisition will come as soon as possible because both companies will want access to capital to continue expansion progress and other yet to be announced plans. This is considering the fact that they cannot increase AS without going current first.
Our SS update will be viewable at 9pm pst/12am est tonight. I expect the AS/OS to be maxed at 4 bil
Looking at TTC* DD (I’m comparing LAHO) as TTC* has a near identical SS (TTC* OS is 3.4 billion & AS is 5.1 billion) to LAHO and that company doesn’t have nearly the revenue or potential that GSCG has. TTC* has $2.4 million in liabilities confirmed from the recent 10Q (03/2019) and $3,984 in cash. It recently reduced the AS to 4.5 billion (from 6 billion) before increasing it in July to 5.1 billion & launched a new platform resulting in the most recent run. It also has a shell risk designation though it is current with the SEC. But LAHO, if confirmed by filings, could have between $29mil to $100+ mil revenues annually and is rapidly expanding. LAHO also has hired new auditors to produce audited financials for SEC compliance before September 12th (within 90 days from June 12 PR). TTC* was able to hit .0329 on 07/23/19 for its 52wk high (with the potential to go higher as it sets a higher base) with a similar SS and less stellar attributes in comparison to us. With that said, GSCG (upon closing of the RM before Halloween) has enormous potential in the coming weeks/months. This is all with the assumption that the revenue data confirms or exceeds our expectations with future filings.
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
$$LAHO-Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)
R/M binding LOI Signed for Lans Holdings to acquire Global Stem Cells Group (GSCG)
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
GSCG has 36 stem cell centers in 27 countries globally, plus the Adimarket which sells products and recently outfits a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
$$LAHO-Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Lans Holdings Inc. is pleased to announce that it has successfully completed its due diligence as per the binding letter of intent to acquire 100% of Global Stem Cells Group Inc (GSCG).
"We are very pleased to have successfully completed our due diligence," said Dave Christensen, CEO of Lans Holdings, "And we are looking forward to the closing of the acquisition."
The company has engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
This press release should be read in conjunction with the 8K filed on July 29, 2019 on www.sec.gov
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
ADDITIONAL LAHO DD:
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
LMAO! Good observation. I think we will be just fine. This will be in penny land before Thanksgiving
With all due respect, we are still bullish as we remain well above the 50 day MA. Support at .001 hasn’t even needed to be tested as we sit above the 50. So please be accurate in your statements. Pps moving up and down a few ticks does not signal a bearish pattern.
$LAHO - Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE
Lans Holdings Inc. is pleased to announce that it has successfully completed its due diligence as per the binding letter of intent to acquire 100% of Global Stem Cells Group Inc (GSCG).
"We are very pleased to have successfully completed our due diligence," said Dave Christensen, CEO of Lans Holdings, "And we are looking forward to the closing of the acquisition."
The company has engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
This press release should be read in conjunction with the 8K filed on July 29, 2019 on www.sec.gov
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
***MORE LAHO DD:
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
$$LAHO-Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
ADDITIONAL LAHO DD:
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
Those selling down here right now are either inexperienced, uninformed, or impatience or perhaps all of the above. This isn’t even scratching the surface of it potential. This will be above a penny before this acquisition closes. I expect current status to be announced before the final closing of the transaction. Plus there are unknown positive catalysts we know nothing about that are in the works from GSCG
It never hit 18 in the last run. It hit 17 but remember they have maxed out the OS now so they cannot dilute. This is just MM flushing stop orders and scare tactics
Wrong ticker
90 days for current status from June 12 PR is middle of September. They will likely go current by end of August if I guessed. Who knows where the price will be by then. That should send the pps much higher after that catalyst comes to fruition.
$$LAHO-Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Lans Holdings Inc. is pleased to announce that it has successfully completed its due diligence as per the binding letter of intent to acquire 100% of Global Stem Cells Group Inc (GSCG).
"We are very pleased to have successfully completed our due diligence," said Dave Christensen, CEO of Lans Holdings, "And we are looking forward to the closing of the acquisition."
The company has engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
This press release should be read in conjunction with the 8K filed on July 29, 2019 on www.sec.gov
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
ADDITIONAL LAHO DD:
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
They already made that money during the dilution period in June. We are golden here. The key resistance is at .0017 which is the 52wk high. If we crack that we could be in store for a nice blue sky breakout
#13 on Breakout Boards!
#1Most Read!
#1 Most Posted Today
MAXM and other MMs moving to .01 & .03. Foreshadowing?
Wilma called me back and asked what she should do because someone from our board keeps harassing her. I told her to buy out the flippers shares and send that person on his way as LAHO is about to move up massively.
Again, it has not penetrated the market yet. The 8k is filed with SEC but the OTC market site doesn’t update instantaneously. It won’t appear until later today. A lot of people have not seen the news yet. I just woke up to see it within the last hour. I’m glad I continued to add despite all the negativity that was here from some folks
$LAHO - Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE
Lans Holdings Inc. is pleased to announce that it has successfully completed its due diligence as per the binding letter of intent to acquire 100% of Global Stem Cells Group Inc (GSCG).
"We are very pleased to have successfully completed our due diligence," said Dave Christensen, CEO of Lans Holdings, "And we are looking forward to the closing of the acquisition."
The company has engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
This press release should be read in conjunction with the 8K filed on July 29, 2019 on www.sec.gov
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
***MORE LAHO DD:
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
$$LAHO-Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
ADDITIONAL LAHO DD:
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
$$LAHO-Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Lans Holdings Inc. is pleased to announce that it has successfully completed its due diligence as per the binding letter of intent to acquire 100% of Global Stem Cells Group Inc (GSCG).
"We are very pleased to have successfully completed our due diligence," said Dave Christensen, CEO of Lans Holdings, "And we are looking forward to the closing of the acquisition."
The company has engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
This press release should be read in conjunction with the 8K filed on July 29, 2019 on www.sec.gov
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
ADDITIONAL LAHO DD:
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117